NVNO 250117 7.50C (NVNO250117C7500) Stock Options, News & Quotes

0.00
0.000.00%

15min DelayTrading Dec 26 09:30 ET

0.00High0.00Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Trytosaveabit

Dec 16 07:55

Update

$enVVeno Medical (NVNO.US)$ EnVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for EnVVe
Accesswire· 5 mins ago
Successful Completion of All Planned Implants in GLP Study
enVVe Delivery System Demonstrates Consistent Performance
Company Maintains Timeline for IDE Application Submission by Mid-2025, Pending GLP Study Results

Jaguar8

Dec 16 07:52

NEWS

$enVVeno Medical (NVNO.US)$
enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe
Monday, 16th December at 8:50 am
Successful Completion of All Planned Implants in GLP Study
enVVe Delivery System Demonstrates Consistent Performance
Company Maintains Timeline for IDE Application Submission by Mid-2025, Pending GLP Study Results
IRVINE, CA / ACCESSWIRE / December 16, 2024 / enVVeno Medical Corporation (NASDAQ: NVNO) ("enVVeno" or the "Company"), a com...

Trytosaveabit

Nov 19 07:19

News

$enVVeno Medical (NVNO.US)$ enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
3 MINUTES AGO, 8:15 AM EST
VIA ACCESSWIRE
Definitive One Year Data from PMA Application to be Presented Wednesday at 51st Annual VEITH Symposium
Company to Host a Conference Call with the PIs Presenting the Pivotal Trial Data on Wednesday, November 20th at 2:00 PM Eastern Time

Jaguar8

Nov 19 07:16

NEWS

$enVVeno Medical (NVNO.US)$
enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
enVVeno Medical has submitted its PMA application to the FDA for the VenoValve, seeking marketing and sales approval in the United States. Four out of five modules have been approved, with the final module containing clinical data from the SAVVE pivotal trial and proposed labeling.
The FDA-designated breakthrough device aims to treat severe deep venous Chronic Venous Insufficiency (CVI), ta...

Trytosaveabit

Oct 28 07:38

Update

$enVVeno Medical (NVNO.US)$ enVVeno Medical Successfully Initiates 6-Month Pre-Clinical GLP Study Evaluating enVVe(R)
7 MINUTES AGO, 8:30 AM EDT
VIA ACCESSWIRE
First wave of implants successfully completed with updated delivery system performing very well
Company on schedule to be in position to apply for approval for enVVe pivotal trial mid-2025